The aim of studying and bibliography

The main aim of study: To familiarize students with the technological operations and chemical processes, the pharmaceutical industry, acting in the production of drugs

The general information about the module: The module is carried out in the second semester. Includes 15 hours of lectures and 15 hours of laboratory exercises.

Teaching materials: Instrukcje laboratoryjne

Bibliography required to complete the module

Bibliography used during lectures

1	Kuczyński L.	Technologia leków	WNT.	1971
2	Ed. Shioiri T., Izawa K., Konoike T	Pharmaceutical Process Chemistry	Wiley-VCH.	2011
3	Red. Janicki S., Fiebig A., Sznitowska M.	Farmacja stosowana	Wydawnictwo Lekarskie PZWL.	2008

Bibliography used during classes/laboratories/others

1

Red. Janicki S., Fiebig A., Sznitowska M.

Farmacja stosowana

Wydawnictwo Lekarskie.

2008

Basic requirements in category knowledge/skills/social competences

Formal requirements: Registration for the second semester.

Basic requirements in category knowledge: Basic knowledge of physical chemistry, inorganic and organic, and the methods of instrumental analysis.

Basic requirements in category skills: Ability to apply basic laboratory techniques.

Basic requirements in category social competences: Awareness of the need to work in teams of 2-3 people

Module outcomes

MEK	The student who completed the module	Types of classes / teaching methods leading to achieving a given outcome of teaching	Methods of verifying every mentioned outcome of teaching	Relationships with KEK	Relationships with PRK
01	He knows the basic operations of the physical and chemical unit processes used in the manufacture of medicated	lecture, laboratory	pass the written, performance monitoring, report writing	K_W05+ K_W08+ K_U08+	P7S_UW P7S_WG
02	He knows the chosen method of preparation of intermediates and final products in the synthesis of drugs	lecture, laboratory	pass the written, performance monitoring, report writing	K_W07+ K_W09+ K_U06+	P7S_UK P7S_UW P7S_WG
03	Able to independently perform experiments performed inflicted product analysis, to draw correct conclusions and prepare the final report, using additional information from the scientific literature.	laboratory	performance monitoring, report writing	K_U08+ K_K02+	P7S_KO P7S_UW

Attention: Depending on the epidemic situation, verification of the achieved learning outcomes specified in the study program, in particular credits and examinations at the end of specific classes, can be implemented remotely (real-time meetings).

The syllabus of the module

Sem.	TK	The content	realized in	MEK
2	TK01	Introduction. Principles classification of drugs, the origin of drugs, factors affecting drug action, side effects of drugs.	W01
2	TK02	Discussion of the technology of the selected therapeutic agents of the following pharmacological groups: hormones, alkaloids and glycosides, vitamins	W02	MEK01 MEK02
2	TK03	Discussion of the technology of the selected therapeutic agents of the pharmacological groups: analgesic and antipyretic, anti-inflammatory agents, local anesthetics, sedatives and hypnotics	W03	MEK01 MEK02
2	TK04	Discussion of the technology of the selected therapeutic agents of the pharmacological groups: analgesics, psychotropic drugs, agents and sympathicotonic, antihypertensive agents	W04	MEK01 MEK02
2	TK05	Discussion of the technology of the selected therapeutic agents of the pharmacological groups: diuretics, anticoagulants, agents with antidiabetic agents, antihistamines	W05	MEK01 MEK02
2	TK06	Technology formulations. Granules, pills, tablets, coated tablets, capsules, emulsions, pharmaceutical ointments, creams, suppositories,	W06	MEK01 MEK02
2	TK07	Synthesis of 3 of pharmaceutical preparations on a laboratory scale	L01-L03	MEK03

The student's effort

The type of classes	The work before classes	The participation in classes	The work after classes
Lecture (sem. 2)		contact hours: 15.00 hours/sem.
Laboratory (sem. 2)	The preparation for a test: 8.00 hours/sem.	contact hours: 15.00 hours/sem.	Finishing/Making the report: 4.00 hours/sem.
Advice (sem. 2)		The participation in Advice: 1.00 hours/sem.
Exam (sem. 2)	The preparation for an Exam: 15.00 hours/sem.	The written exam: 2.00 hours/sem.

The way of giving the component module grades and the final grade

The type of classes	The way of giving the final grade
Lecture	Positive marks of successful completion of the written test. 0-50% pkt - 2,0, 50-60% pkt. - 3,0, 60-70% pkt. 3,5t, 70-80% pkt - 4,0, 80-90% pkt. - 4,5, 90-100% pkt - 5,0
Laboratory	Pass all the exercises set schedule - the correct execution of exercises, a positive result for oral answer, the development of the report).
The final grade	The final mark is issued based on the evaluation of the lecture and laboratory. Final mark (K): K = 0,5W + 0,5L; where: W, L is respectively positive assessment of lecture, laboratory

Sample problems

Required during the exam/when receiving the credit
(-)

Realized during classes/laboratories/projects
(-)

Others
(-)

Can a student use any teaching aids during the exam/when receiving the credit : no

The contents of the module are associated with the research profile: yes

1	K. Bester; A. Bukowska; W. Bukowski; A. Kawka; M. Pytel	Salophen chromium(III) complexes functionalized with pyridinium salts as catalysts for carbon dioxide cycloaddition to epoxides	2024
2	K. Bester; A. Bukowska; W. Bukowski; M. Drajewicz; K. Dychtoń; R. Ostatek; P. Szałański	Sposób wytwarzania salofenowego kompleksu chromu(III)	2024
3	K. Bester; A. Bukowska; W. Bukowski; S. Flaga	Reactive Polymer Composite Microparticles Based on Glycidyl Methacrylate and Magnetite Nanoparticles	2024
4	A. Bukowska; T. Galek; M. Przywara; R. Przywara; W. Zapała	Brief Analysis of Selected Sorption and Physicochemical Properties of Three Different Silica-Based Adsorbents	2023
5	K. Bester; A. Bukowska; W. Bukowski; M. Drajewicz; K. Dychtoń; R. Ostatek; P. Szałański	Ligand salphenowy oraz sposób syntezy tego ligandu salphenowego	2023
6	K. Bester; A. Bukowska; W. Bukowski	Homogeniczny katalizator chromowy, sposób jego wytwarzania, układ katalityczny zawierający ten katalizator oraz zastosowanie tego układu katalitycznego	2021
7	K. Bester; A. Bukowska; W. Bukowski; M. Pytel	Polymer Beads Decorated with Dendritic Systems as Supports for A3 Coupling Catalysts	2021
8	K. Bester; A. Bukowska; W. Bukowski; M. Pytel; A. Sobota	Copolymerization of Phthalic Anhydride with Epoxides Catalyzed by Amine-Bis(Phenolate) Chromium(III) Complexes	2021
9	A. Bukowska; A. Drelinkiewicz; D. Duraczyńska; L. Lityńska-Dobrzyńska; E. Serwicka; R. Socha; M. Zimowska	Solvent and substituent effects in hydrogenation of aromatic ketones over Ru/polymer catalyst under very mild conditions	2019
10	K. Bester; A. Bukowska; W. Bukowski	Homogeniczny katalizator chromowy, sposób jego wytwarzania, układ katalityczny zawierający ten katalizator oraz zatosowanie tego układu katalitycznego	2019